Page 10 - 中国全科医学2022-15

http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·1799·

gastro.2016.02.031. ［18］GABER C E，KINLAW A C，EDWARDS J K，et al. Comparative
［4］SULTAN S，MALHOTRA A. Irritable bowel syndrome［J］. effectiveness and harms of antibiotics for outpatient diverticulitis：
Ann Intern Med，2017，166（11）：ITC81-96. DOI： two nationwide cohort studies［J］. Ann Intern Med，2021，174（6）：
10.7326/AITC201706060. 737-746. DOI：10.7326/M20-6315.
［5］HÄUSER W，MARSCHALL U，LAYER P，et al. The ［19］DESAI R J，FRANKLIN J M. Alternative approaches for
prevalence，comorbidity，management and costs of irritable bowel confounding adjustment in observational studies using weighting
syndrome［J］. Dtsch Arztebl Int，2019，116（27/28）：463- based on the propensity score：a primer for practitioners［J］.
470. DOI：10.3238/arztebl.2019.0463. BMJ，2019，367：l5657. DOI：10.1136/bmj.l5657.
［6］GWEE K A，GHOSHAL U C，CHEN M H. Irritable bowel syndrome ［20］WANG Y Y，LIU Y T，LV Q Q，et al. Effect and safety of Chinese
in Asia：pathogenesis，natural history，epidemiology，and herbal medicine granules in patients with severe coronavirus disease
management［J］. J Gastroenterol Hepatol，2018，33（1）：99- 2019 in Wuhan，China：a retrospective，single-center study with
110. DOI：10.1111/jgh.13987. propensity score matching［J］. Phytomedicine，2021，85：
［7］FLACCO M E，MANZOLI L，DE GIORGIO R，et al. 153404. DOI：10.1016/j.phymed.2020.153404.
Costs of irritable bowel syndrome in European countries with ［21］XU L L，ZHANG S F，WANG Y L，et al. The efficacy of long-
universal healthcare coverage：a meta-analysis［J］. Eur Rev
term Chinese herbal medicine use on lung cancer survival time：
Med Pharmacol Sci，2019，23（7）：2986-3000. DOI：
a retrospective two-center cohort study with propensity score
10.26355/eurrev_201904_17580.
matching［J］. Evid Based Complement Alternat Med，2021，
［8］ZHANG F，XIANG W，LI C Y，et al. Economic burden of irritable
2021：5522934. DOI：10.1155/2021/5522934.
bowel syndrome in China［J］. World J Gastroenterol，2016，22（47）：
［22］GUO J C，PAN H C，YEH B Y，et al. Associations between using
10450-10460. DOI：10.3748/wjg.v22.i47.10450.
Chinese herbal medicine and long-term outcome among pre-dialysis
［9］PEERY A F，CROCKETT S D，MURPHY C C，et al. Burden and
diabetic nephropathy patients：a retrospective population-based
cost of gastrointestinal，liver，and pancreatic diseases in the United
cohort study［J］. Front Pharmacol，2021，12：616522. DOI：
States：update 2018［J］. Gastroenterology，2019，156（1）：
10.3389/fphar.2021.616522.
254-272.e11. DOI：10.1053/j.gastro.2018.08.063.
［23］WU Y B，DAI Y K，ZHANG L，et al. Pharmacological treatments
［10］BLACK C J，STAUDACHER H M，FORD A C. Efficacy of
of Chinese herbal medicine for irritable bowel syndrome in adults：
a low FODMAP diet in irritable bowel syndrome：systematic
a network meta-analysis of randomized controlled trials［J］.
review and network meta-analysis［J］. Gut，2021. DOI：
PLoS One，2021，16（8）：e0255665. DOI：10.1371/journal.
10.1136/gutjnl-2021-325214.
pone.0255665.
［11］CHEN M，TANG T C，QIN D，et al. Pharmacologic treatments
［24］PEI L X，GENG H，GUO J，et al. Effect of acupuncture in patients
for irritable bowel syndrome：an umbrella systematic review［J］.
with irritable bowel syndrome：a randomized controlled trial［J］.
J Gastrointestin Liver Dis，2020，29（2）：199-209. DOI：
Mayo Clin Proc，2020，95（8）：1671-1683. DOI：10.1016/j.
10.15403/jgld-817.
mayocp.2020.01.042.
［12］WU I X Y，WONG C H L，HO R S T，et al. Acupuncture and
［25］LIU B Y，WU J N，YAN S Y，et al. Electroacupuncture vs
related therapies for treating irritable bowel syndrome：overview
of systematic reviews and network meta-analysis［J］. Therap prucalopride for severe chronic constipation：a multicenter，
Adv Gastroenterol，2019，12：1756284818820438. DOI： randomized，controlled，noninferiority trial［J］. Am J
10.1177/1756284818820438. Gastroenterol，2021，116（5）：1024-1035. DOI：
［13］NEUMAN H B，GREENBERG C C. Comparative effectiveness 10.14309/ajg.0000000000001050.
research：opportunities in surgical oncology［J］. Semin ［26］CHEN Y D，JIN X Q，YU M H，et al. Acupuncture for
Radiat Oncol，2014，24（1）：43-48. DOI：10.1016/j. moderate to severe allergic rhinitis：a non-randomized controlled
semradonc.2013.09.003. trial［J］. Chin J Integr Med，2016，22（7）：518-524. DOI：
［14］NACI H，SALCHER-KONRAD M，KESSELHEIM A S，et al. 10.1007/s11655-016-2453-x.
Generating comparative evidence on new drugs and devices before ［27］SIGNOROVITCH J E，WU E Q，BETTS K A，et al. Comparative
approval［J］. Lancet，2020，395（10228）：986-997. DOI： efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid
10.1016/S0140-6736（19）33178-2. leukemia：a matching-adjusted indirect comparison of randomized
［15］CIPRIANI A，IOANNIDIS J P A，ROTHWELL P M，et al. trials［J］. Curr Med Res Opin，2011，27（6）：1263-1271.
Generating comparative evidence on new drugs and devices after DOI：10.1185/03007995.2011.576238.
approval［J］. Lancet，2020，395（10228）：998-1010. DOI： ［28］FIORE L D，LAVORI P W. Integrating randomized comparative
10.1016/S0140-6736（19）33177-0. effectiveness research with patient care［J］. N Engl J Med，
［16］MANHEIMER E，WIELAND L S，CHENG K，et al. Acupuncture 2016，374（22）：2152-2158. DOI：10.1056/NEJMra1510057.
for irritable bowel syndrome：systematic review and meta- ［29］陈敏 . 针刺治疗肠易激综合征病例注册登记研究［EB/
analysis［J］. Am J Gastroenterol，2012，107（6）：835-848. OL］. ［2022-01-03］. http：//www.chictr.org.cn/showproj.
DOI：10.1038/ajg.2012.66. aspx?proj=124852.
［17］YAN J，MIAO Z W，LU J，et al. Acupuncture plus Chinese herbal ［30］曹红波，商洪才 . 比较效果研究的内涵和外延及其用于中医临
medicine for irritable bowel syndrome with diarrhea：a systematic 床评价的可行性分析［J］. 中西医结合学报，2012，10（4）：
review and meta-analysis［J］. Evid Based Complement Alternat 369-374. DOI：10.3736/jcim20120403.
Med，2019，2019：7680963. DOI：10.1155/2019/7680963. CAO H B，SHANG H C. Connotations and extensions of